Open AccessSafety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
Author(s) -
Edgar Turner Overton,
Jack Stapleton,
Ian Frank,
Shawn Hassler,
Paul A Goepfert,
Paul Chaplin
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv183
Subject(s) - vaccinia , smallpox vaccine , medicine , immunogenicity , virology , smallpox , modified vaccinia ankara , human immunodeficiency virus (hiv) , poxviridae , vaccination , immunology , antibody , biology , gene , biochemistry , recombinant dna
[This corrects the article DOI: 10.1093/ofid/ofv040.].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom